Jvion’s inception was driven by a passion to build a prescriptive analytic solution that stops preventable harm. A solution that precisely and comprehensively foresees risk and—more importantly—provides the best recommended actions that will improve outcomes. Jvion helps healthcare systems prevent patient harm and associated costs by enabling clinical staff to focus attention, resources, and individualized interventions on patients whose outcomes can be improved. Unlike traditional AI and predictive analytic solutions that merely identify high-risk patients and cause alarm fatigue, Jvion pinpoints the impactable patients who are on a risk trajectory that can be changed and provides the patient-specific recommendations that will drive to a better outcome. The Jvion MachineTM is a combination of Eigen-based mathematics, dataset of more than 30 million patients, and software that can be quickly applied to any of 50 preventable harm vectors (such as sepsis, readmissions, falls, avoidable ER visits, and pressure injuries) without the need to create new models or to have perfect data.
Total Funding: $8.9 M
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 101 to 250
Founded: 2011
